BusinessCidara Therapeutics Reports Unfavorable Results of Phase 2 RADIANT Trial of CD101 Topical in VVCBy Nasdaq OMXFeb 21, 2017, 12:30 PM UTC
BusinessCidara Therapeutics to Present at the Stifel 2016 Healthcare ConferenceBy Nasdaq OMXNov 8, 2016, 9:05 PM UTC